⚠ DCF unavailable: the interest classification in operating cash flow is unverified, so operating cash flow cannot be reconciled to FCFF. Financial evidence and eligible comparables remain available. · Peers swapped to "GLP-1 + obesity platform" cohort: Ozempic/Wegovy market-share leader. Same secular driver as LLY.

上次更新 2026-10-28 · 資料來源：SEC EDGAR 13F、美國國會 STOCK Act 申報
非投資建議。13F 每季申報，最多落後 45 天；國會申報同樣最多落後 45 天，而且只揭露金額區間，不是精確金額。